Cookies?
Library Header Image
LSE Research Online LSE Library Services

How should functionally equivalent drugs be reimbursed? A retrospective analysis of reimbursement for Epoetin-[alpha] and Darbepoetin-[alpha] in 2001-2003 and the cost implications for CMS

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Saka, Ömer R (2005) How should functionally equivalent drugs be reimbursed? A retrospective analysis of reimbursement for Epoetin-[alpha] and Darbepoetin-[alpha] in 2001-2003 and the cost implications for CMS. Disease Management and Health Outcomes, 13 (6). pp. 359-370. ISSN 1173-8790

Full text not available from this repository.

Item Type: Article
Official URL: http://diseasemanagement.adisonline.com/
Additional Information: © 2005 Adis International Ltd
Divisions: Social Policy
European Institute
LSE Health
Subjects: R Medicine > RA Public aspects of medicine
Date Deposited: 04 Sep 2008 15:42
Last Modified: 04 Jan 2024 03:45
URI: http://eprints.lse.ac.uk/id/eprint/15045

Actions (login required)

View Item View Item